Correlation Between Novo Nordisk and Qrons
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Qrons at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Qrons into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Qrons Inc, you can compare the effects of market volatilities on Novo Nordisk and Qrons and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Qrons. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Qrons.
Diversification Opportunities for Novo Nordisk and Qrons
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Novo and Qrons is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Qrons Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qrons Inc and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Qrons. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qrons Inc has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Qrons go up and down completely randomly.
Pair Corralation between Novo Nordisk and Qrons
Assuming the 90 days horizon Novo Nordisk is expected to generate 1.7 times less return on investment than Qrons. But when comparing it to its historical volatility, Novo Nordisk AS is 1.23 times less risky than Qrons. It trades about 0.16 of its potential returns per unit of risk. Qrons Inc is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 16.00 in Qrons Inc on September 13, 2024 and sell it today you would earn a total of 2.00 from holding Qrons Inc or generate 12.5% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 95.65% |
Values | Daily Returns |
Novo Nordisk AS vs. Qrons Inc
Performance |
Timeline |
Novo Nordisk AS |
Qrons Inc |
Novo Nordisk and Qrons Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Novo Nordisk and Qrons
The main advantage of trading using opposite Novo Nordisk and Qrons positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Qrons can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qrons will offset losses from the drop in Qrons' long position.Novo Nordisk vs. Sino Biopharmaceutical Ltd | Novo Nordisk vs. Defence Therapeutics | Novo Nordisk vs. Aileron Therapeutics | Novo Nordisk vs. Enlivex Therapeutics |
Qrons vs. Northwest Biotherapeutics | Qrons vs. Geron | Qrons vs. Advanced Proteome Therapeutics | Qrons vs. Oxford BioDynamics Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |